Adage Capital Partners
SGMO

Adage Capital Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Adage Capital Partners’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-950,000
Closed -$10.9M – 732
2018
Q4 		$10.9M Sell
950,000
-450,000
-32% -$5.59M 0.03% 493
2018
Q3 		$23.7M Sell
1,400,000
-1,850,000
-57% -$28.1M 0.05% 364
2018
Q2 		$46.1M Buy
3,250,000
+950,000
+41% +$15.8M 0.11% 238
2018
Q1 		$43.7M Sell
2,300,000
-100,000
-4% -$2.14M 0.1% 249
2017
Q4 		$39.4M Sell
2,400,000
-800,000
-25% -$11.9M 0.09% 271
2017
Q3 		$48M Sell
3,200,000
-800,000
-20% -$8.84M 0.12% 229
2017
Q2 		$35.2M Buy
4,000,000
+1,000,000
+33% +$6.42M 0.09% 304
2017
Q1 		$15.6M Buy
3,000,000
+500,000
+20% +$2.01M 0.04% 451
2016
Q4 		$7.63M Hold
2,500,000
– – 0.02% 564
2016
Q3 		$11.6M Hold
2,500,000
– – 0.03% 495
2016
Q2 		$14.5M Buy
2,500,000
+650,000
+35% +$4.14M 0.04% 440
2016
Q1 		$11.2M Buy
1,850,000
+950,000
+106% +$5.7M 0.03% 496
2015
Q4 		$8.22M Hold
900,000
– – 0.02% 552
2015
Q3 		$5.08M Sell
900,000
-450,000
-33% -$3.71M 0.01% 614
2015
Q2 		$15M Buy
1,350,000
+50,000
+4% +$645K 0.04% 475
2015
Q1 		$20.4M Sell
1,300,000
-1,000,000
-43% -$15.5M 0.05% 415
2014
Q4 		$35M Sell
2,300,000
-250,000
-10% -$3.04M 0.09% 291
2014
Q3 		$27.5M Hold
2,550,000
– – 0.07% 326
2014
Q2 		$38.9M Sell
2,550,000
-250,000
-9% -$3.6M 0.1% 255
2014
Q1 		$50.6M Sell
2,800,000
-750,000
-21% -$14.5M 0.14% 197
2013
Q4 		$49.3M Sell
3,550,000
-177,800
-5% -$2.05M 0.13% 216
2013
Q3 		$39.1M Buy
3,727,800
+2,327,800
+166% +$23.1M 0.11% 238
2013
Q2 		$10.9M Buy
+1,400,000
New +$12.2M 0.03% 485

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Adage Capital Partners's SGMO Position: Q1 2019 in Review

Adage Capital Partners sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2019, closing a stake of 950,000 shares — an estimated $10.9M sold.

Adage Capital Partners first reported a position in SGMO in Q2 2013 and held it in 23 quarters. The position peaked at $50.6M in Q1 2014. 187 funds tracked by Wall St. Rank hold SGMO as of Q1 2019.

  • Adage Capital Partners reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2019 after selling out during the quarter.
  • Adage Capital Partners sold 950,000 SANGAMO THERAPEUTICS INC shares in Q1 2019, an estimated $10.9M.
  • Adage Capital Partners first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 23 quarters.
  • Adage Capital Partners's SANGAMO THERAPEUTICS INC position peaked at $50.6M in Q1 2014.
  • 187 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2019.

Based on Adage Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.